Literature DB >> 14761719

Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.

Ming-Fang Cheng1, Kwok-Woon Yu, Ran-Bin Tang, Yu-Hua Fan, Yun-Liang Yang, Kai-Sheng Hsieh, Monto Ho, Hsiu-Jung Lo.   

Abstract

Susceptibilities to amphotericin B and fluconazole of 383 Candida species isolated from blood were determined. Candida albicans was the most common species (55.6%), followed by Candida parapsilosis (17.5%), Candida tropicalis (16.5%), Candida glabrata (5.2%), Candida guilliermondii (2.3%), and others (2.9%). All but three isolates, Candida ciferrii, C. tropicalis, and C. glabrata, one each, were susceptible to amphotericin B. A total of 367 (95.8%) and 15 (4.2%) isolates were susceptible and susceptible-dose dependent to fluconazole, respectively. Only one isolate, a C. glabrata, was resistant to fluconazole. Few patients (13%) having prior fluconazole treatments may explain the low rate of resistance to fluconazole in this study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14761719     DOI: 10.1016/j.diagmicrobio.2003.08.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  26 in total

1.  R432 is a key residue for the multiple functions of Ndt80p in Candida albicans.

Authors:  Yun Liang Yang; Chih Wei Wang; Shiang Ning Leaw; Te Pin Chang; I Chin Wang; Chia Geun Chen; Jen Chung Fan; Kuo Yun Tseng; Szu Hsuan Huang; Chih Yu Chen; Ting Yin Hsiao; Chao Agnes Hsiung; Chiung Tong Chen; Chwan Deng Hsiao; Hsiu Jung Lo
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Oropharyngeal colonization of HIV-infected outpatients in Taiwan by yeast pathogens.

Authors:  Yun-Liang Yang; Chien-Ching Hung; An-Huei Wang; Fan-Chen Tseng; Shiang Ning Leaw; Yu-Tzu Tseng; Chia-Li Su; Hui-Ting Chen; Tsai-Ling Lauderdale; Hsiu-Jung Lo
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

Review 3.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.

Authors:  C P Girish Kumar; Ahmed Medhat Hanafy; Masakazu Katsu; Yuzuru Mikami; Thangam Menon
Journal:  Mycopathologia       Date:  2006-03       Impact factor: 2.574

Review 5.  Candida and invasive candidiasis: back to basics.

Authors:  C S-Y Lim; R Rosli; H F Seow; P P Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-05       Impact factor: 3.267

6.  Differential phytate utilization in Candida species.

Authors:  Paul Wai-Kei Tsang
Journal:  Mycopathologia       Date:  2011-07-27       Impact factor: 2.574

7.  Candida guilliermondii fungemia in patients with hematologic malignancies.

Authors:  Corrado Girmenia; Giampaolo Pizzarelli; Francesco Cristini; Francesco Barchiesi; Elisabetta Spreghini; Giorgio Scalise; Pietro Martino
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

8.  Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

Authors:  M A Pfaller; S A Messer; L Boyken; S Tendolkar; R J Hollis; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

10.  Species distribution and susceptibility profile of Candida species in a Brazilian public tertiary hospital.

Authors:  Ariane Bruder-Nascimento; Carlos Henrique Camargo; Maria Fátima Sugizaki; Terue Sadatsune; Augusto Cezar Montelli; Alessandro Lia Mondelli; Eduardo Bagagli
Journal:  BMC Res Notes       Date:  2010-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.